Catherine T Maguire
CIK 1480678 · View on SEC EDGAR ↗
Insider
First SEC filing: March 14, 2013 · Latest: March 14, 2013
On this page
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 15 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Feb. 17, 2015 | MED | A | 5,000 | — | — | 10,000 Direct | +100.00% | Acquired | (price as of 2026-08-21) |
| Feb. 17, 2015 | MED | A | 1,250 | — | — | 15,074 Direct | +9.04% | Acquired | (price as of 2026-08-21) |
| Dec. 31, 2014 | MED | A | 153 | — | — | 13,824 Direct | +1.12% | Acquired | (price as of 2026-08-21) |
| Sept. 30, 2014 | MED | A | 156 | — | — | 13,671 Direct | +1.15% | Acquired | (price as of 2026-08-21) |
| June 30, 2014 | MED | A | 158 | — | — | 13,515 Direct | +1.18% | Acquired | (price as of 2026-08-21) |
| March 31, 2014 | MED | A | 165 | — | — | 13,357 Direct | +1.25% | Acquired | (price as of 2026-08-21) |
| Feb. 5, 2014 | MED | A | 5,000 | — | — | 5,000 Direct | — | Acquired | (price as of 2026-08-21) |
| Feb. 5, 2014 | MED | A | 750 | — | — | 13,192 Direct | +6.03% | Acquired | (price as of 2026-08-21) |
| Dec. 31, 2013 | MED | A | 183 | — | — | 12,442 Direct | +1.49% | Acquired | (price as of 2026-08-21) |
| Sept. 30, 2013 | MED | A | 179 | — | — | 12,259 Direct | +1.48% | Acquired | (price as of 2026-08-21) |
| June 30, 2013 | MED | A | 186 | — | — | 12,080 Direct | +1.56% | Acquired | (price as of 2026-08-21) |
| March 31, 2013 | MED | A | 215 | — | — | 11,894 Direct | +1.84% | Acquired | (price as of 2026-08-21) |
| Feb. 19, 2013 | MED | A | 750 | — | — | 11,679 Direct | +6.86% | Acquired | (price as of 2026-08-21) |
| June 20, 2011 | MED | A | 1,036 | $22.40 | $23,206 | 9,819 Direct | +11.80% | Acquired | -47.5% (price as of 2026-08-21) |
| April 6, 2010 | MED | A | 283 | $26.52 | $7,505 | 8,783 Direct | +3.33% | Acquired | -55.7% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 17, 2015 | MED | Stock Option | Common Stock (5,000) | $31.55 | Feb. 17, 2025 | 5,000 | Acquired |
| Feb. 5, 2014 | MED | Stock Option | Common Stock (5,000) | $26.52 | Feb. 5, 2024 | 5,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).